---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-002808"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2026-07-06T20:02:00+00:00"
generated_at: "2026-07-06T20:03:10.238312+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma issues 4.27M shares to CEO and PFO to cancel $1.15M in debt

## Summary
- CEO Ram Mukunda receives 2,226,475 shares for cancellation of $601,148 owed, including $283,639 in cash advances.
- VP/PFO Claudia Grimaldi receives 2,048,378 shares for cancellation of $553,062 owed, including $268,723 in cash advances.
- Total debt reduction of $1,154,210; no cash paid by the Company; equity increases by same amount.
- Shares issued at $0.27 per share; transaction approved by independent directors and Audit Committee under Rule 16b-3.
- Shares are restricted, unregistered, and issued under Section 4(a)(2) exemption; resale subject to securities laws.

## SEC filing metadata
- accession: 0001185185-26-002808
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2026-07-06T20:02:00+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518526002808/0001185185-26-002808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526002808/igc8k070626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-002808
- JSON: https://secwatch.observer/filing/0001185185-26-002808.json
- Plain text: https://secwatch.observer/filing/0001185185-26-002808.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.